Quantitative Drug Safety and Benefit Risk Evaluation: Practical and Cross-disciplinary Approaches - Couverture souple

Livre 129 sur 151: Chapman & Hall/CRC Biostatistics
 
9781032191119: Quantitative Drug Safety and Benefit Risk Evaluation: Practical and Cross-disciplinary Approaches
Couverture souple
ISBN 10 : 1032191112 ISBN 13 : 9781032191119
Editeur : Chapman & Hall/CRC, 2024

Synopsis

This book provides a comprehensive coverage on safety monitoring methodologies, covering both global trends and regional initiatives. Pharmacovigilance has traditionally focused on the handling of individual adverse event reports however recently there had been a shift towards aggregate analysis to better understand the scope of product risks.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

À propos de l?auteur

Dr. William (Bill) Wang is currently Executive Director in the department of Biostatistics and Research Decision Sciences, Merck Research Laboratories, where he has worked for 20+ years. Bill has served as the deputy topics-leader for the ICH E17 Working Group and has co-chaired the ASA Biopharmaceutical Safety Working Group. He is an elected ASA Fellow.

Dr. Melvin S. Munsaka is currently Senior Director and Head of Safety Statistics at AbbVie. He has more than 25 years of industry experience. He is a member of the ASA Biopharmaceutical Safety Scientific Working Group, DIA Bayesian Scientific Working Group, and the PHUSE Safety Analytics Working Group

Dr. James Buchanan, president of Covilance LLC, has 30+ years of drug safety experience in the pharmaceutical industry. He is a co-lead of the ASA Biopharmaceutical Safety Working Group and the Interactive Safety Graphics taskforce that is developing novel, open-source, interactive graphical tools to evaluate drug safety issues.

Dr. Judy X. Li is currently Senior Director, Biostatistics Lead for San Diego site Bristol Myers Squibb. She also has extensive experience working at the US Food and Drug Administration as a master statistical reviewer and supervisory mathematical statistician. She is the founding co-chair of the ASA Biopharmaceutical Safety Working Group.

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

Éditeur
Chapman & Hall/CRC
Date d'édition
2024
Langue
anglais
ISBN 10 
1032191112
ISBN 13 
9781032191119
Reliure
Broché
Nombre de pages
382
Éditeur
Wang William, Munsaka Melvin, Buchanan James, Li Judy
Coordonnées du fabricant
non disponible
Personne responsable
non disponible

Autres éditions populaires du même titre

9781138594067: Quantitative Drug Safety and Benefit Risk Evaluation

Edition présentée

ISBN 10 :  1138594067 ISBN 13 :  9781138594067
Editeur : Chapman and Hall/CRC, 2021
Couverture rigide